WT
Wellcome Trust Portfolio holdings
AUM
$8.67B
This Quarter Return
+9.5%
1 Year Return
+21.23%
3 Year Return
+70.19%
5 Year Return
+91.77%
10 Year Return
+339.01%
AUM
$8.67B
AUM Growth
+$8.67B
(+8.3%)
Cap. Flow
+$56.7M
Cap. Flow
% of AUM
0.65%
Top 10 Holdings %
Top 10 Hldgs %
68.96%
Holding
20
New
–
Increased
3
Reduced
–
Closed
–
Top Buys
| 1 |
ServiceNow
NOW
|
$25.7M |
| 2 |
Mastercard
MA
|
$22.5M |
| 3 |
Adobe
ADBE
|
$8.5M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 32.53% |
| 2 | Financials | 19.58% |
| 3 | Consumer Discretionary | 19.35% |
| 4 | Healthcare | 12.09% |
| 5 | Communication Services | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Visa
V
$683B
| $852M | 9.83% | 2,400,000 | – | – |
|
2
Microsoft
MSFT
$3.77T
| $746M | 8.61% | 1,500,000 | – | – |
|
3
DoorDash
DASH
$105B
| $740M | 8.53% | 3,000,000 | – | – |
|
4
Amazon
AMZN
$2.44T
| $724M | 8.36% | 3,300,000 | – | – |
|
5
Apple
AAPL
$3.45T
| $574M | 6.63% | 2,800,000 | – | – |
|
6
Linde
LIN
$224B
| $525M | 6.06% | 1,120,000 | – | – |
|
7
Berkshire Hathaway Class A
BRK.A
$1.09T
| $510M | 5.89% | 700 | – | – |
|
|
8
ServiceNow
NOW
$190B
| $463M | 5.34% | 450,000 +25,000 | +6% | +$25.7M |
|
9
Abbott
ABT
$231B
| $425M | 4.91% | 3,125,000 | – | – |
|
10
Cisco
CSCO
$274B
| $416M | 4.8% | 6,000,000 | – | – |
|
11
Edwards Lifesciences
EW
$47.8B
| $375M | 4.33% | 4,800,000 | – | – |
|
|
12
Mastercard
MA
$538B
| $334M | 3.86% | 595,000 +40,000 | +7% | +$22.5M |
|
13
Accenture
ACN
$162B
| $329M | 3.79% | 1,100,000 | – | – |
|
14
Alphabet (Google) Class C
GOOG
$2.58T
| $319M | 3.68% | 1,800,000 | – | – |
|
|
15
Alphabet (Google) Class A
GOOGL
$2.57T
| $317M | 3.66% | 1,800,000 | – | – |
|
|
16
Adobe
ADBE
$151B
| $290M | 3.35% | 750,000 +21,962 | +3% | +$8.5M |
|
17
PepsiCo
PEP
$204B
| $264M | 3.05% | 2,000,000 | – | – |
|
18
Johnson & Johnson
JNJ
$427B
| $244M | 2.82% | 1,600,000 | – | – |
|
19
Nike
NKE
$114B
| $213M | 2.46% | 3,000,000 | – | – |
|
20
Neumora Therapeutics
NMRA
$280M
| $2.43M | 0.03% | 3,309,123 | – | – |
|